Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

TG Therapeutics Price Quote

$13.99
+0.17 (+1.23%)
(Updated: April 18, 2024 at 6:55 PM ET)

TG Therapeutics Key Stats

Sell
38
TG Therapeutics (TGTX) is a Sell

Day range:
$13.85 - $14.63
52-week range:
$6.46 - $35.67
Dividend yield:
0%
P/E ratio:
153.61
P/S ratio:
8.78
P/B ratio:
13.3%

Volume:
3.1M
Avg. volume:
2.7M
1-year change:
-32.75%
Market cap:
$2.1B
Revenue:
$233.7M
EPS:
$0.01

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 548.64%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went down by -9.2% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price fell by -32.75% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $100.1M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $217.5M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.06

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.4M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $72.7M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$50.7M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is 7.75%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 4.98%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is 14.03%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • Editas Medicine Inc (EDIT)
    • Amicus Therapeutics Inc (FOLD)
    • Geron Corp (GERN)
    • G1 Therapeutics Inc (GTHX)
    • Mersana Therapeutics Inc (MRSN)

TG Therapeutics Dividend Yield

Data Unavailable

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.92%
Revenue: 54863.75% 9.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 29.75
Upside from Last Price: 115.27%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    132.9M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22M TGTX shares are owned by insiders